Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19.
Ontology highlight
ABSTRACT: BACKGROUND:Coronavirus disease 2019 (Covid-19) may disproportionately affect people with cardiovascular disease. Concern has been aroused regarding a potential harmful effect of angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) in this clinical context. METHODS:Using an observational database from 169 hospitals in Asia, Europe, and North America, we evaluated the relationship of cardiovascular disease and drug therapy with in-hospital death among hospitalized patients with Covid-19 who were admitted between December 20, 2019, and March 15, 2020, and were recorded in the Surgical Outcomes Collaborative registry as having either died in the hospital or survived to discharge as of March 28, 2020. RESULTS:Of the 8910 patients with Covid-19 for whom dischar
SUBMITTER: Mehra MR
PROVIDER: S-EPMC7206931 | biostudies-literature | 2020 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA